Recent Visitors
Samantha L. Wilson PhDSamantha L. Wilson PhD
Cecilia J. Hillard PhDCecilia J. Hillard PhD
Michael P. Mccauley PhDMichael P. Mccauley PhD
Joan C. Gill MDJoan C. Gill MD
Michael Farrell MDMichael Farrell MD

Meghen B. Browning MD Online Profile

Meghen B. Browning MD

Assistant Professor
Medical College of Wisconsin
Department: Pediatrics
Division: Hematology/Oncology
Program: Oncology


Research Experience

  • Immunotherapy
  • Neuroblastoma

    • Clinical Expertise

  • Neoplasms, Bone Tissue
  • Neoplasms, Germ Cell and Embryonal
  • Neuroblastoma
  • Osteosarcoma
  • Rhabdomyosarcoma
  • Sarcoma, Ewing's
  • Soft Tissue Neoplasms

    • Publications

  • Expanding the phenotype of multifocal lymphangioendotheliomatosis with thrombocytopenia. (Maronn M, Catrine K, North P, Browning MB, Kerschner JE, Noel R, Drolet BA, Kelly M) Pediatr Blood Cancer 2009 Apr;52(4):531-4 PMID 19058203
  • Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis. (Keever-Taylor CA, Browning MB, Johnson BD, Truitt RL, Bredeson CN, Behn B, Tsao A) Cytotherapy 2007;9(2):144-57 PMID 17453966
  • The T cell activation marker CD150 can be used to identify alloantigen-activated CD4(+)25+ regulatory T cells. (Browning MB, Woodliff JE, Konkol MC, Pati NT, Ghosh S, Truitt RL, Johnson BD) Cell Immunol 2004 Feb;227(2):129-39 PMID 15135295
  • The surgeon's role in pediatric orbital malignancies: an oncologist's perspective. (Browning MB, Camitta BM) Ophthal Plast Reconstr Surg 2003 Sep;19(5):340-4 PMID 14506417

    • Grants and Awards

  • Liposomal Muramyl Triprepdide Phosphatidly Ethonolamide (L-MTP_PE): Compassionate Access for High-Risk Osteosarcoma (#9305274 06/30/2009 - 06/29/2013) Sponsor: Millennium Pharmaceutical Inc